{"schema_version":"secwatch.filing_event.v1","accession":"0001510964-22-000072","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2022-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.977659+00:00","generated_at":"2026-06-23T21:19:33.953701+00:00","sec_items":["1.01","1.02","7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CV Sciences issues $2M secured note, extinguishes convertible debt to reduce dilution","bullets":["Entered $2M secured promissory note with Streeterville Capital; net proceeds $1.59M after $400K OID and $10K fees.","Terminated existing $1.06M convertible note from 3i, LP by paying $675K settlement amount.","CEO states elimination of convertible debt removes dilutive stock issuance and downward price pressure.","Maturity of new note is 9 months from Aug 19, 2022; accelerated repayment from any CARES Act proceeds received."],"urls":{"canonical":"https://secwatch.observer/filing/0001510964-22-000072","json":"https://secwatch.observer/filing/0001510964-22-000072.json","markdown":"https://secwatch.observer/filing/0001510964-22-000072.md","text":"https://secwatch.observer/filing/0001510964-22-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000072/0001510964-22-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000072/cvsi-20220819.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:19:33.953701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}